Upgrade to SI Premium - Free Trial

Wolfe Research Upgrades Sarepta Therapeutics (SRPT) to Outperform

July 8, 2026 5:07 PM
(Updated - July 8, 2026 5:08 PM EDT)

Wolfe Research analyst Andy Chen upgraded Sarepta Therapeutics (NASDAQ: SRPT) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades